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Clarification of the nature of the proteins involved in the cleavage of C3b and C4b 
is of great interest because these complement fragments are opsonins and, in addition, 
they modulate the activities of several key enzymes of the complement cascade. When 
these  complement  peptides  are  in  solution,  proteolysis  by  a  serum  enzyme,  C3b- 
inactivator  (C3bINA),  1 requires  cofactors: fllH  in  the case of C3b and C4-binding 
protein (C4-bp) or C3b-C4blNA cofactor in the case of C4b (1-4). 
Some uncertainties remain regarding the activities of the cofactors. The observations 
of Whaley and Ruddy (5) strongly suggest that only fllH, among all serum proteins 
separated  by molecular sieve  chromatography, accelerates  the  inactivation  of cell- 
bound C3b  by C3bINA, whereas  the  results  of Nagasawa and  Stroud  (4)  indicate 
that, in addition to fllH, the C3b-C4bINA cofactor can also function in the cleavage 
of fluid phase C3b by C3bINA. Other sources of complication are that preparations 
of the  cofactors  are  frequently  cross-contaminated  and  that  C4-bp  contains  two 
proteins  that  are antigenically identical  but  display slight  differences  in  molecular 
weight and net charges (6). 
In the present paper we report the isolation of both forms of C4-bp and compare 
their activities, as well as that offllH, on cell-bound and fluid phase C3b and C4b. 
In  addition,  we  studied  the  relationship  between  C4-bp  and  the  C3b-C4bINA 
co  factor. 
Materials and Methods 
Materials.  N,N'-methylene-bis-acrylamide,  acrylamide, N,N,N',N',  tetramethylene diamine, 
ammonium persulfate, sodium dodecyl sulfate (SDS), Bio-Rad Laboratories,  Richmond, Calif.; 
diisopropylfluorophosphate  (DFP), Calbiochem-Behring  Corp., American  Hoechst Corp., San 
Diego, Calif.; bovine serum albumin (BSA), Miles Laboratories,  Inc., Miles Research Products, 
Elkhart,  Ind.; Sepharose  CL-6B, CNBr-activated  Sepharose  4B,  Pharmacia Fine Chemicals, 
Division of Pharmacia, Inc., Piscataway, N.J.; trypsin, soybean trypsin inhibitor, Worthington 
Biochemical Corp., Freehold, N. J.; DEAE-cellulose (DE-52), Whatman Chemicals, Division of 
W & R Balston, Maidstone,  Kent, England. 
Buffers 
DCVB:  gelatin veronal buffer, pH 7.4 containing 5% dextrose, 0.1% gelatin, 0.15 mM CaCI2, 
and 0.5 mM MgC12. 
EDTA-GVB.  gelatin  veronal buffer containing 0.01 M EDTA. 
* Supported by National Institutes of Health grants AI-08499,  AI-13224,  and CA-16247. 
1 Abbreviations used in thzs paper: A, antibody; C3bINA,  C3b inactivator; C4-bp, C4-binding protein; C4- 
bp low, or high, C4-binding protein of low or high molecular weight; CIE, crossed immunoelectrophoresis; 
DFP, diisopropylfluorophosphate; DGVB, dextrose gelatin veronal buffer; E, sheep erythrocytes; RIE, 
rocket immunoelectrophoresis; SDS-PAGE,  sodium dodecyl  sulfate-polyacrylamide  slab; gel electrophore- 
sis. 
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Antisera.  Rabbit antisera to human C3bINA and IgM were purchased from Kent Labora- 
tories, North Vancouver, British Columbia, and Behring Diagnostics, American Hoechst Corp., 
Somerville, N. J., respectively. Anti-filH and anti-C4-bp were prepared in our laboratory by 
injecting rabbits with the purified proteins incorporated in complete Freund's adjuvant. Anti- 
C3b-C4bINA cofactor was  a  gift  from  Dr.  Robert J.  Wyatt, Childrens' Hospital Research 
Foundation, Cincinnati, Ohio. 
Preparation oflmmunoadsorbents.  Purified C4b and the IgG fractions of anti-flirt, C4-bp, and 
IgM, obtained by DEAE-cellulose chromatography were coupled to CNBr-activated Sepharose 
4B according to the directions of the manufacturer. 
Purified Complement Components.  Guinea pig C1 and C2 (7), human C4 (8), C3 (9), P  (10), B 
(11),  D  (12),  fllH (13),  and C3bINA (14)  were purified by previously published techniques. 
Guinea pig serum diluted 1:50 in EDTA-GVB served as a source of C3-C9. 
C4b  and  radiolabeled C4b were prepared as described previously (2).  C3b  was prepared 
from purified C3 as described by Bokisch et al.  (15).  C3b was radiolabeled with ~zsI by the 
method described in (16).  Specific activity was 4  ×  10  s cpm//zg protein. 
Two  forms of C4-bp which differ slightly in molecular weight  (C4-bp low or high)  were 
separated  by  the  method  previously described  (6)  with  minor  modifications. The  starting 
material, a euglobulin fraction of serum obtained by 1/5 dilution in water containing 2 mM 
EDTA, pH  7.4,  was subjected to chromatography on  DEAE  Sephadex A-50. The fractions 
enriched  in  C4-bp  low  or high  were  further  purified by passage on  Bio-Rex  70  (Bio-Rad 
Laboratories, Richmond, Calif.) and molecular sieve chromatography on Sepharose 6B. Addi- 
tional contaminants, such as fllH and IgM were removed by passage through Sepharose 4B 
conjugated with the IgG fraction of monospecific antisera. 
By SDS-polyacrylamide gel electrophoresis (PAGE), the preparation of C4-bp high (0.3 mg/ 
/~1) showed a single band. However, C4-bp low was contaminated with C4-bp high. The amount 
of contamination was estimated to be 23% by counting the radioactivity in the stained bands 
of radiolabeled C4-bp low after SDS-PAGE. When SDS-PAGE was performed under reducing 
conditions, a single polypeptide chain, mol wt 75,000, was observed in the preparations of both 
C4-bp high and low (Fig. 1). 
The  protein concentrations of purified C4-bp  and  C4  were  estimated by the  method  of 
Lowry using bovine serum albumin as the reference protein (17). In the ease of C3bINA, ~ 1  H, 
B, D, and P, the protein concentrations were calculated from their optical densities at 280 nm, 
assuming that an absorption coefficient value of 1.0 equals 1 mg/ml. 
Measurement of the Interaction between fllH with Cell-Bound C3b.  The assay which we used was 
based on the ability of/~IH to accelerate the inactivation of cell-bound C3b by C3bINA (5). 
Two different types of C3b-bearing cells were used: (a) EAC4b3b cells with limited C3b sites, 
or (b) EC3b cells were prepared by mixing an equal volume of E(1  ×  109/ml) and purified C3 
(400 #g/ml) with  1% trypsin (wt/wt of C3). After incubation at 37°C for 3 min, the reaction 
was stopped by adding  1% soybean trypsin inhibitor and  the cells washed three times with 
DGVB. 
Fractions containing fllH and C4-bp were assayed as follows: 100/xl  of EAC4b3b or EC3b 
cells (1.5  ×  108/ml), 50/.tl of C3bINA (2/.tg/ml), and 50 #1 of test samples were incubated in 
EDTA-GVB at 37°C for 30 min. The cells were washed twice with DGVB and resuspended in 
0.3 ml of DGVB containing B  (6 #g/ml) and D  (0.2/~g/ml). After incubation at 37°C for  15 
rain, the resulting cells were further incubated at 37°C for 1 h with 1.2 ml of C3-C9. Controls 
consisted of EAC4b3b or EC3b incubated with C3bINA alone or with EDTA-GVB. The tubes 
were centrifuged, and the hemoglobin in the supernate was measured spectrophotometrically 
at 414 rim. 
On the basis of the percent hemolysis observed, the average number of hemolytic sites per 
cell (Z) was calculated. Inhibition of hemolysis, which reflects inactivation of C3b, was expressed 
as percentage inhibition of hemolytic sites. 
Analytical Procedures.  Crossed  (CIE)  and  rocket  (RIE)  immunoelectrophoresis and  SDS- 
PAGE were performed as described previously (2,  16,  18). 
Results 
Presence of Two Distinct Cofactors  for Cleavage of C3b by C3bINA in the Euglobulin Fraction 
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Fro.  1.  Preparations of purified C4-bp low, and  C4-bp high analyzed by SDS-PAGE under 
nonreducing and reducing conditions. A, B, and C show C4-bp low, C4-bp high, and a mixture of 
both. The concentrations of acrylamide in the stacking and running gels were 3-4.5% (left panel) or 
3-7.5% (right panel). C4-bp low is contaminated with ~23% of C4-bp high (see text). 
weight protein could also function as a  cofactor in the cleavage of C3b by C3blNA 
(4),  we examined the possibility that  these two activities could be separated  by gel 
filtration.  50  ml  of serum  treated  with  DFP  were  diluted  five  times  with  water 
containing 2  mM  EDTA, pH  7.4.  After 60 min at 0°C,  a  euglobulin fraction was 
separated by centrifugation. Fig. 2 shows the results of assays performed in fractions 
obtained  after  the  passage of this  euglobulin  fraction  through a  Sepharose CL-6B 
column. 
Three protein peaks were obtained. C4-bp protein first appeared in the ascending 
portion of the second protein peak with an apparent mol wt of 1,200,000./~  1H protein 
eluted between the second and third protein peaks with a  mol wt of 300,000. 
Fractions were first  tested  for their ability to enhance the activity of C3blNA on 
EAC4b3b ceils (5). The peak of activity coincided precisely with the position of 131H. 
No activity was associated with  C4-bp. To rule out the possibility that  the lack of 
activity  of C4-bp  on  cell-bound  C3b  was  a  result  of the  presence  of C4b  on  the 
EAC4h3b cells we repeated  the  assay using  EC3b.  Again, /~IH  produced a  strong 
dose-dependent inhibition of the hemolytic activity of EC3b, whereas C4-bp had no 
effect even at high concentrations (Fig.  3). 
Next,  the same fractions were  incubated  with  radiolabeled  C3b  and  C3blNA at 
37°C for 1 h. After denaturation and reduction of the proteins with SDS, urea, and 
2-mercaptoethanol, the mixtures were subjected to SDS-PAGE. Fig. 2,  D  shows the 
radioautography.  It  is clear  that  the  a'-chain of C3b  was cleaved when  incubated 
with fractions containing/~IH (76-80) or C4-bp (56-60). 
In  view  of these  results,  we  proceeded  to  isolate  the  two  varieties  of C4-bp  to 
determine  whether both would function as  cofactors in  the cleavage of fluid  phase 
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Fie.  2.  Cofactor activity for C3b-inactivator in fractions obtained after passage of serum euglob- 
ulin through a Sepharose CL-6B column. The euglobulin fraction was applied to a Sepharose CL- 
6B column (2.6  ×  90) equilibrated with phosphate-buffered saline containing 2 mM EDTA. The 
OD of the fractions are shown in panel A. The arrows point to the positions of the peaks oflgM and 
IgG when chromatographed through the same column. C4-bp and ~IH antigen were measured by 
rocket immunoelectrophoresis (panel B).  The ability of fractions containing/~IH to enhance the 
inhibitory activity of C3blNA on cell-bound C3b is shown in panel C. Panel D shows the cleavage 
of fluid  phase  C3b  obtained  by  mixing  purified  C3blNA  with  the  fractions.  12~I-C3b (15  ~1 
containing 2/Lg of protein and 6  ×  104 cpm) were incubated with C3bINA (5/d, 0.4 #g) and 30 
pl of each individual fraction for  1 h  at 370C.  Negative controls consisted of xe~I-C3b alone (first 
column from left to right). Positive control (second column from left to right) was a mixture of 12~I- 
C3b, C3bINA, and/~IH (10/.tl,  2/~g protein). After incubation, 50 pl of a solution containing 2% 
SDS, 6 M  urea, and 10% 2-mercaptoethanol was added, and the mixtures were applied to 3-7.5% 
SDS-PAGE.  The  slab gel  was stained, dried,  and subjected  to  radioautography.  Two  peaks of 
activity, coinciding with the positions of ]31H and C4-bp antigens, were detected  (76-80 and 56- 
60). 
Cofactor Activity  of the  Two  Forms of C4-bp  in  the  Cleavage of C4b  and  C3b.  In  the 
experiments  shown in Fig. 4, decreasing amounts  of the two varieties of C4-bp  (C4-bp 
low, C4-bp  high) were added  to a  constant  amount  of C4b and C3bINA.  The  reaction 
mixtures  were  incubated  at  37°C  for  1 h  and  subjected  to SDS-PAGE.  The  a'-chain 
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Fxo.  3.  Effect of C4-bp and ~IH on the hemolytic activity of cell-bound C3b. Dilutions of purified 
C4-bp  and  /~IH  were  incubated  with  EC3b  bearing  1.02  C3b  sites per  cell  in  the  presence  of 
C3bINA.  The  residual  average number of hemolytic C3b  sites was  determined  as  described  in 
Methods./~IH, but not C4-bp, markedly inhibited the hemolytic activity of EC3b in the presence 
of C3bINA. C3bINA alone reduced the total number of hemolytic sites from  1.02  to 0.41. ~IH or 
C4-bp alone had no effect on EC3b. 
FIG.  4.  Cleavage of C4b by C3bINA and C4-bp low (L) or C4-bp high (H). 1~5I-C4b (30 #1 and 8 
×  104 cpm) and 5 #l of C3bINA were incubated with decreasing amounts of C4-bp low and C4-bp 
high for 1 h at 37 ° in a 45-#1 total volume. The reaction mixtures were applied to a  10% SDS-PAGE 
under reducing conditions, followed by radioautography. With either form of C4-bp, the a'-chain 
of C4b was cleaved to the same extent. 272  C4-BINDING  PROTEIN  AND fllH IN  PROTEOLYSIS  OF C4b AND C3b 
FIG. 5.  Cleavage  of C3b by C3blNA in the presence offllH, C4-bp low (L), or C4-bp high (H). 
125I-C3b (15/tl and 6  ×  104 cpm) and 5/.tl C3bINA were incubated with decreasing amounts of 
fllH, C4-bp high, or C4-bp low for 1 h at 37°C in a 60-#1 total volume. The mixtures were analyzed 
by 7.5% SDS-PAGE under reducing conditions. The radiography demonstrates that C3bINA and 
fllH cleaved the a'-chain of C3b into two peptides with mol wt of 65,000 (a'-65) and 40,000 (a'-40). 
Incubation with C4-bp high or C4-bp low resulted in the fragmentation of the a'-chain into three 
peptides; that  is, a'-65, a'-40, and a minor band with an apparent mol wt of 45,000. This minor 
band disappeared when the amounts of C3bINA and C4-bp were increased in relation to 12sI-C3b. 
This is shown in the last track on the right side of the figure. 
The specific cofactor activities of C4-bp high or low are quite similar, as evaluated by the extent 
of cleavage of the a'-chain of C3b. 
(a4). On the basis of the extent of cleavage shown in the radioautography, and taking 
into account that C4-bp low is slightly contaminated with C4-bp high (Methods), we 
estimate that both forms of C4-bp have similar specific activities. 
Next, we evaluated the effects offllH, C4-bp low, and C4-bp high on the structure 
of C3b.  When  labeled  C3b  was  treated  with  a  constant  amount of C3bINA and 
decreasing amounts of fllH,  the  extent  of cleavage of C3b  was  dependent on  the 
concentration of fllH  (Fig. 5). The a'-chain of C3b was cleaved into two fragments 
with apparent mol wt of 65,000 and 40,000, and the fl-chain remained intact. 
Treatment of C3b  with  C3bINA and C4-bp  low or  C4-bp  high  resulted  in the 
fragmentation of the a'-chain of C3b into three peptides (Fig. 5). Two of them (a'-65 
and a'-40) were in identical positions to those resulting from the activity offllH. An 
additional minor band was seen in a  position corresponding to a  mol wt  of 45,000 
(a'-45). When C3bINA and C4-bp were added to smaller amounts of C3b, this extra 
band disappeared (Fig. 5, additional track). 
To rule out the possibility that other serine proteases contaminated our reagents, 
the same experiments were carried out in the presence of DFP (5  ×  10  -3 M). Results 
were identical. 
In summary, we found no qualitative differences between fllH and the two forms 
of  C4-bp  in  their  role  as  cofactors  in  the  cleavage  of  fluid  phase  C3b.  Other 
investigators  found  that  C3bINA  and  fllH  cleave  the  a'-chain  of  C3b  into  two TEIZO  FUJITA AND VICTOR  NUSSENZWEIG  273 
Fxc. 6.  Inhibition of the interaction  between C3b, C3bINA,  and C4-bp  by purified C4b.  10-/~l 
samples of C4-bp were incubated with decreasing amounts  of C4b at 37°C for 30 rain. Then,  10 
/LI of ~2sI-C3b (2 ~g) and 5/~1 C3bINA were added and the mixtures further incubated at 37°C for 
1 h. Results were analyzed after 3-7.5% SDS-PAGE under reducing conditions and radioautography. 
In the absence of C4b, the 0t'-chain of C3b was cleaved into two fragments. In the presence of C4b, 
the cleavage of C3b was inhibited, and the degree of inhibition was dependent  on the dose of C4b. 
fragments  (1) which probably correspond to a'-65 and a'-40. The origin of the a'-45 
fragment  is  not  clear.  One  possibility is  that  it  is  an  intermediate  product  which 
precedes the appearance of a'-40 as reported by Harrison and Lachmann  (19). 
On the basis of many titrations such as those shown  in Fig. 5, we estimate that  the 
efficiency of fll H  to serve as cofactor for cleavage of C3b is ~20-fold greater than C4- 
bp low or high on the basis of protein concentration. 
The Specificity  of the Effects of C4-bp and C3b.  The possibility that  the effects of C4- 
bp  on  C3b  were  a  result  of contamination  with  J~IH  was  studied  in  additional 
experiments. C4-bp was  further purified by affinity chromatography through  Seph- 
arose 4B-C4b or by passage through an anti-j~lH Sepharose column. Its activity was 
not  altered.  When  purified  C4-bp  was  passed  through  an  anti-C4-bp  Sepharose 
column, the cofactor activities for both C4b and C3b were removed. 
In addition, C4b inhibited the effect of C4-bp on the cleavage of C3b by C3bINA. 
In the experiment shown  in  Fig. 6, decreasing amounts of C4b were incubated with 
a constant amount of C4-bp at 37°C for 30 min. Then, radiolabeled C3b and C3bINA 
were  added  to  the  mixture.  After  an  additional  incubation  at  37°C  for  1  h,  the 
samples were analyzed by SDS-PAGE and radioautography. The stained gel showed 
the  characteristic  pattern  of degradation  of the  a'-chain  of C4b  (not  shown).  The 
radioautography  demonstrates  a  dose-dependent  inhibitory  effect  of C4b  on  the 
cleavage of C3b. 
We conclude that C4-bp, as well as J~IH, can serve as cofactors for the cleavage of 
fluid phase C3b, and that C4b and C3b compete for C4-bp binding sites. 
Identity  between C4-bp and C3b-C4bINA  Cofactor.  The  results above show a  striking 
functional  similarity between  C4-bp  and  the  cofactor described  by  Stroud  and  his 274  C4-BINDING  PROTEIN  AND /~IH  IN  PROTEOLYSIS  OF  C4b  AND  C3b 
associates (3, 4). C4-bp and C3b-C4b co-factor are high molecular weight fl-globulins 
with sedimentation coefficients 10-11S, and consisting of subunits of mol wt between 
70 and 80,000. 
We recently compared the specificities of antisera to C4-bp and to the C3b-C4bINA 
cofactor.  Both  were  monospecific, as  shown  by crossed  immunoelectrophoresis of 
whole human serum or plasma. In double diffusion in agarose against purified C4-bp 
a reaction of identity between both antisera was obtained. 
Discussion 
As previously described, most or all normal human sera contain different propor- 
tions of two forms of C4-bp  (C4-bp  low and  C4-bp  high),  which  differ slightly in 
molecular weight and net charge. Although the nature of this structural heterogeneity 
is unknown, both of them bind specifically to C4b and can be immunoprecipitated 
with  antisera  to  C4-bp  (6).  We  show  here  that  C4-bp  low  and  high  cannot  be 
distinguished functionally when assayed as cofactors for the cleavage of the a'-chain 
of C4b by C3bINA; the specific activities are quite similar and the fragments of C4b 
which are generated have identical molecular weights. 
In addition, we found that both proteins can serve as cofactors for the cleavage of 
C3b in solution, and in this respect C4-bp resembles fllH (1). Because/~IH and C4- 
bp share some physico-chemical properties, and purified preparations of either protein 
are frequently cross-contaminated, we considered the possibility that this activity of 
C4-bp was a result of contaminating fllH. However, we could not detect fllH in our 
preparations of C4-bp (300 #g/ml) by RIE, CIE, or by SDS-PAGE. The activity on 
C3b was fully preserved when C4-bp was passed through a  Sepharose 4B-anti-flirt 
column, or after further purification of C4-bp by affinity chromatography on Seph- 
arose 4B-C4b. Furthermore, highly purified C4b inhibited the cofactor activity of C4- 
bp on C3b, but it had no effect on the cofactor activity offllH. 
Although C4-bp and fllH, together with C3bINA, had similar qualitative effects 
on fluid phase C3b, several important quantitative differences in their activities were 
observed.  For  example,  fllH  diminished  the  hemolytic  activity  of EC3b,  in  the 
presence of C3bINA,  at  concentrations of 0.05/~g/ml,  whereas C4-bp  was without 
effect even at a  16/~g/ml concentration. Therefore, C4-bp  is at least  320 times less 
effective than/31H when assayed for effects on cell-bound C3b.  In relation to fluid 
phase C3b, C4-bp appeared to be about 20 times less effective than fllH on a weight 
basis.  Because the concentration of fllH in  normal serum  (500/xg/ml)  (13)  is  also 
higher than that of C4-bp  (250/xg/ml, T. Fujita and V. Nussenzweig, unpublished 
observations) our results indicate that under physiological conditions the functions of 
C3b are mainly controlled by fllH. 
The  present  findings  show  a  striking  homology  between  the  requirements  for 
cleavage for C3b and C4b in solution by C3bINA.  In both instances an additional 
binding protein is necessary: fllH (or secondarily C4-bp) in the case of C3b, and C4- 
bp in the case of C4b. The mechanisms by which these regulatory proteins carry out 
their function are not entirely clear. Their effects may be mediated by the formation 
of complexes with C4b (6) or C3b (20, 21). The substrate of C3bINA may be the a'- 
chain of C3b or C4b modified allosterically by the interaction with fllH and C4-bp. 
If this concept is correct, our results could indicate that fluid phase C3b has a higher 
binding  affinity for/~IH than  for C4-bp,  and  that  cell-associated C3b  exclusively TEIZO FUJITA AND VICTOR  NUSSENZWEIG  275 
binds filH. Whatever the reasons may be for the remarkable differences in suscepti- 
bility of cell-bound versus free C3b to C4-bp and C3bINA, our observations support 
the concept that the effects of the regulatory proteins are greatly influenced by the 
microenvironment in which the reaction takes place (21, 22). 
We also examined the relationship between C4-bp and the C3b-C4bINA cofactor 
described  by Stroud  and  his  collaborators  (3,  4).  On  the  basis  of its  activity, the 
Stroud cofactor resembles C4-bp, as shown in this report and previous papers (2). In 
addition, we found that antiserum monospecific to the cofactor reacts with purifed 
C4-bp  and  gives a  reaction of identity with  an antiserum  to C4-bp.  Therefore, by 
functional, physico-chemical and immunological criteria, C4-bp and the C3b-C4bINA 
cofactor are the same protein. 
Summary 
Two forms of C4-binding protein  (C4-bp)  (C4-bp low, C4-bp  high), which differ 
slightly in net charge and apparent molecular weight, as determined by SDS-PAGE, 
were separated  by ion-exchange chromatography and  contaminants  removed with 
specific antisera. Both forms of C4-bp served as cofactors for the cleavage of C4b in 
solution by C3b inactivator, and the resulting fragments of the a'-chain of C4b had 
identical molecular weights. In addition, similarly to/31H, C4-bp low or high served 
as  cofactors for the cleavage of fluid phase C3b  by C3bINA.  However, important 
quantitative differences between the activities of C4-bp and ~ 1H were observed. With 
regard to C3b in solution, the cofactor activity of ~IH was 220 times greater than 
that  of C4-bp  on a  weight  basis.  In  relation to cell-bound C3b,  the  differences in 
activity were even more marked. Whereas/~IH enhanced the effects of C3bINA on 
the erythrocyte intermediate EC3b, inhibiting the assembly of EC3bBb, C4-bp was 
without effect even at concentrations 2--300 times greater than ~IH. Therefore, under 
physiological conditions, it is likely that filH is the key protein which controls the 
function of C3b, and that C4-bp activity is directed mainly toward the cleavage of 
C4b. 
We  also  examined  the  relation  between  C4-bp  and  the  C3b-C4bINA  cofactor 
described by Stroud and  collaborators  (3,  4).  By functional, physico-chemical and 
immunological criteria, they are the same protein. 
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